— High blood pressure, liver problems and heart disease risk upped in heavy kids.
Hepatitis C in the News Your source for hepatitis C-related news from around the web.
Not sure what to submit? Read our news guidelines first.
— Researchers say treatment has fewer side effects and less risk of rejection, too.
— First human tests looked at safety.
— Researchers conclude Sovaldi is cost-effective.
— Combination pill, taken once a day, blocks enzymes that virus needs to multiply.
People who are cured of hepatitis C live just about as long as those who never had the disease to begin with, according to research published today in the Journal of the American Medical Association. The researchers followed 530 patients in the Netherlands with chronic hepatitis C infection for a…
— Viral infection comes from contaminated food, water or contact with infected person.
Federal approval of new drugs to treat the hepatitis C virus (HCV) represents "a dramatic, positive development for patients," says University at Buffalo liver disease expert Andrew H. Talal, MD. In October, the U.S. Food and Drug Administration approved the first HCV treatments that cure patients without interferon.
— Heavier people might be more prone to liver cancer, insulin problems, researchers say.
— New study echoes prior findings and suggests caffeine isn't the key ingredient in the effect.